Literature DB >> 10841026

Cyclic AMP a key messenger in the regulation of skin pigmentation.

R Buscà1, R Ballotti.   

Abstract

Compelling evidence has been gathered indicating that pro-opiomelanocortin peptides, alpha-melanocyte stimulating hormone (alpha-MSH) and adrenocorticotropic hormone (ACTH), through the cyclic AMP pathway, play a pivotal role in melanocyte differentiation and in the regulation of melanogenesis. Recently, the molecular events linking cAMP to melanogenesis up-regulation have been elucidated. This cascade involves the activation of protein kinase A and CREB transcription factor, leading to the up-regulation of the expression of Microphthalmia associated transcription factor (MITF). MITF has been found mutated in patients with Waardenburg syndrome 2A, and plays a crucial role in melanocyte development. MITF binds and activates melanogenic gene promoters, thereby increasing their expression which results in an increased melanin synthesis. Beyond this simplified scheme, It appears that melanogenic gene expression is controlled by a complex network of regulation involving other transcription factors such as Brn2, TBX2, PAX3 and SOX10. Further studies are required to better understand the respective roles of these factors in the regulation of melanin synthesis. In addition, other intracellular signaling pathways, like the phosphatidyl inositol 3-kinase pathway, as well as the molecular cascade of events governed by the small GTP-binding protein Rho, seem to be involved in the regulation of melanogenesis and melanocyte dendricity. Finally, it should be mentioned that cAMP activates a melanocyte-specific pathway leading to MAP kinase activation. MAP kinase, ERK2, phosphorylates MITF, thereby targeting the transcription factor to proteasomes for degradation. Thus, in addition to the complex transcriptional regulation, melanogenesis is also subjected to a post-translational regulation that controls MITF or tyrosinase function. Taken together, these complex molecular processes would finally allow a fine tuning of melanocyte differentiation leading to melanin synthesis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10841026     DOI: 10.1034/j.1600-0749.2000.130203.x

Source DB:  PubMed          Journal:  Pigment Cell Res        ISSN: 0893-5785


  181 in total

Review 1.  Shining light on skin pigmentation: the darker and the brighter side of effects of UV radiation.

Authors:  Nityanand Maddodi; Ashika Jayanthy; Vijayasaradhi Setaluri
Journal:  Photochem Photobiol       Date:  2012-04-12       Impact factor: 3.421

Review 2.  MC1R, eumelanin and pheomelanin: their role in determining the susceptibility to skin cancer.

Authors:  Tahseen H Nasti; Laura Timares
Journal:  Photochem Photobiol       Date:  2014-11-07       Impact factor: 3.421

3.  Suppression of melanin production by expression of HSP70.

Authors:  Tatsuya Hoshino; Minoru Matsuda; Yasuhiro Yamashita; Masaya Takehara; Masayo Fukuya; Kazutaka Mineda; Daisuke Maji; Hironobu Ihn; Hiroaki Adachi; Gen Sobue; Yoko Funasaka; Tohru Mizushima
Journal:  J Biol Chem       Date:  2010-02-22       Impact factor: 5.157

4.  CRH functions as a growth factor/cytokine in the skin.

Authors:  A Slominski; B Zbytek; A Pisarchik; R M Slominski; M A Zmijewski; J Wortsman
Journal:  J Cell Physiol       Date:  2006-03       Impact factor: 6.384

5.  SOX9 is a key player in ultraviolet B-induced melanocyte differentiation and pigmentation.

Authors:  Thierry Passeron; Julio C Valencia; Corine Bertolotto; Toshihiko Hoashi; Elodie Le Pape; Kaoruko Takahashi; Robert Ballotti; Vincent J Hearing
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-16       Impact factor: 11.205

6.  Downregulation of melanocyte-specific facultative melanogenesis by 4-hydroxy-3-methoxycinnamaldehyde acting as a cAMP antagonist.

Authors:  Eunmiri Roh; In-Yeong Jeong; Hyoeun Shin; Sukgil Song; Nam Doo Kim; Sang-Hun Jung; Jin Tae Hong; Seung Ho Lee; Sang-Bae Han; Youngsoo Kim
Journal:  J Invest Dermatol       Date:  2013-08-07       Impact factor: 8.551

7.  2-Ethoxybenzamide stimulates melanin synthesis in B16F1 melanoma cells via the CREB signaling pathway.

Authors:  Kazuomi Sato; Ryosuke Ando; Honoka Kobayashi; Takashi Nishio
Journal:  Mol Cell Biochem       Date:  2016-09-16       Impact factor: 3.396

Review 8.  MC1R, the cAMP pathway, and the response to solar UV: extending the horizon beyond pigmentation.

Authors:  Jose C García-Borrón; Zalfa Abdel-Malek; Celia Jiménez-Cervantes
Journal:  Pigment Cell Melanoma Res       Date:  2014-05-30       Impact factor: 4.693

9.  Lyoniresinol inhibits melanogenic activity through the induction of microphthalmia-associated transcription factor and extracellular receptor kinase activation.

Authors:  Huiyu Liu; Xiaoxin Sui; Xiaohong Li; Yuzhen Li
Journal:  Mol Cell Biochem       Date:  2012-10-26       Impact factor: 3.396

10.  cAMP-dependent activation of protein kinase A as a therapeutic target of skin hyperpigmentation by diphenylmethylene hydrazinecarbothioamide.

Authors:  Hyoeun Shin; Seung Deok Hong; Eunmiri Roh; Sang-Hun Jung; Won-Jea Cho; Sun Hong Park; Da Young Yoon; Seon Mi Ko; Bang Yeon Hwang; Jin Tae Hong; Tae-Young Heo; Sang-Bae Han; Youngsoo Kim
Journal:  Br J Pharmacol       Date:  2015-04-24       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.